Logo image of MELI

MERCADOLIBRE INC (MELI) Stock Fundamental Analysis

NASDAQ:MELI - Nasdaq - US58733R1023 - Common Stock - Currency: USD

2413.57  +62.43 (+2.66%)

After market: 2413.57 0 (0%)

Fundamental Rating

7

Overall MELI gets a fundamental rating of 7 out of 10. We evaluated MELI against 28 industry peers in the Broadline Retail industry. MELI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MELI is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, MELI could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

MELI had positive earnings in the past year.
MELI had a positive operating cash flow in the past year.
MELI had positive earnings in 4 of the past 5 years.
Each year in the past 5 years MELI had a positive operating cash flow.
MELI Yearly Net Income VS EBIT VS OCF VS FCFMELI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

MELI has a Return On Assets of 7.45%. This is in the better half of the industry: MELI outperforms 75.00% of its industry peers.
With an excellent Return On Equity value of 41.19%, MELI belongs to the best of the industry, outperforming 96.43% of the companies in the same industry.
The Return On Invested Capital of MELI (21.15%) is better than 92.86% of its industry peers.
MELI had an Average Return On Invested Capital over the past 3 years of 18.86%. This is significantly above the industry average of 11.59%.
The 3 year average ROIC (18.86%) for MELI is below the current ROIC(21.15%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.45%
ROE 41.19%
ROIC 21.15%
ROA(3y)5.57%
ROA(5y)3.5%
ROE(3y)34.15%
ROE(5y)21.57%
ROIC(3y)18.86%
ROIC(5y)13.44%
MELI Yearly ROA, ROE, ROICMELI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

1.3 Margins

With an excellent Profit Margin value of 9.21%, MELI belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
In the last couple of years the Profit Margin of MELI has grown nicely.
The Operating Margin of MELI (12.81%) is better than 82.14% of its industry peers.
In the last couple of years the Operating Margin of MELI has grown nicely.
The Gross Margin of MELI (46.13%) is better than 64.29% of its industry peers.
In the last couple of years the Gross Margin of MELI has remained more or less at the same level.
Industry RankSector Rank
OM 12.81%
PM (TTM) 9.21%
GM 46.13%
OM growth 3Y25.83%
OM growth 5YN/A
PM growth 3Y98.37%
PM growth 5YN/A
GM growth 3Y2.74%
GM growth 5Y-0.81%
MELI Yearly Profit, Operating, Gross MarginsMELI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MELI is creating value.
MELI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, MELI has more shares outstanding
Compared to 1 year ago, MELI has an improved debt to assets ratio.
MELI Yearly Shares OutstandingMELI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MELI Yearly Total Debt VS Total AssetsMELI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

MELI has an Altman-Z score of 4.68. This indicates that MELI is financially healthy and has little risk of bankruptcy at the moment.
MELI has a better Altman-Z score (4.68) than 71.43% of its industry peers.
MELI has a debt to FCF ratio of 1.00. This is a very positive value and a sign of high solvency as it would only need 1.00 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.00, MELI belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
A Debt/Equity ratio of 0.57 indicates that MELI is somewhat dependend on debt financing.
MELI's Debt to Equity ratio of 0.57 is on the low side compared to the rest of the industry. MELI is outperformed by 64.29% of its industry peers.
Even though the debt/equity ratio score it not favorable for MELI, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 1
Altman-Z 4.68
ROIC/WACC2.3
WACC9.2%
MELI Yearly LT Debt VS Equity VS FCFMELI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.20 indicates that MELI should not have too much problems paying its short term obligations.
MELI has a worse Current ratio (1.20) than 71.43% of its industry peers.
MELI has a Quick Ratio of 1.18. This is a normal value and indicates that MELI is financially healthy and should not expect problems in meeting its short term obligations.
MELI has a Quick ratio (1.18) which is in line with its industry peers.
MELI does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.18
MELI Yearly Current Assets VS Current LiabilitesMELI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 81.92% over the past year.
Measured over the past years, MELI shows a very strong growth in Earnings Per Share. The EPS has been growing by 172.65% on average per year.
MELI shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.68%.
MELI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 55.35% yearly.
EPS 1Y (TTM)81.92%
EPS 3Y172.65%
EPS 5YN/A
EPS Q2Q%43.66%
Revenue 1Y (TTM)37.68%
Revenue growth 3Y43.24%
Revenue growth 5Y55.35%
Sales Q2Q%36.97%

3.2 Future

MELI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.77% yearly.
MELI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.91% yearly.
EPS Next Y34.07%
EPS Next 2Y36.58%
EPS Next 3Y36.18%
EPS Next 5Y31.77%
Revenue Next Year32.66%
Revenue Next 2Y28.71%
Revenue Next 3Y26.29%
Revenue Next 5Y20.91%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MELI Yearly Revenue VS EstimatesMELI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
MELI Yearly EPS VS EstimatesMELI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 50 100 150 200 250

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 59.36 indicates a quite expensive valuation of MELI.
The rest of the industry has a similar Price/Earnings ratio as MELI.
MELI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.50.
The Price/Forward Earnings ratio is 34.32, which means the current valuation is very expensive for MELI.
60.71% of the companies in the same industry are cheaper than MELI, based on the Price/Forward Earnings ratio.
MELI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 59.36
Fwd PE 34.32
MELI Price Earnings VS Forward Price EarningsMELI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

MELI's Enterprise Value to EBITDA ratio is in line with the industry average.
MELI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MELI is cheaper than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.96
EV/EBITDA 32.13
MELI Per share dataMELI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of MELI may justify a higher PE ratio.
A more expensive valuation may be justified as MELI's earnings are expected to grow with 36.18% in the coming years.
PEG (NY)1.74
PEG (5Y)N/A
EPS Next 2Y36.58%
EPS Next 3Y36.18%

0

5. Dividend

5.1 Amount

MELI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MERCADOLIBRE INC

NASDAQ:MELI (7/18/2025, 8:00:01 PM)

After market: 2413.57 0 (0%)

2413.57

+62.43 (+2.66%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners84.81%
Inst Owner Change0%
Ins Owners0.26%
Ins Owner Change0%
Market Cap122.37B
Analysts82.76
Price Target2878.73 (19.27%)
Short Float %1.48%
Short Ratio1.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.43%
Min EPS beat(2)14.99%
Max EPS beat(2)55.87%
EPS beat(4)3
Avg EPS beat(4)17.01%
Min EPS beat(4)-23.22%
Max EPS beat(4)55.87%
EPS beat(8)6
Avg EPS beat(8)6.84%
EPS beat(12)10
Avg EPS beat(12)12.5%
EPS beat(16)12
Avg EPS beat(16)38.42%
Revenue beat(2)2
Avg Revenue beat(2)3.28%
Min Revenue beat(2)0.98%
Max Revenue beat(2)5.59%
Revenue beat(4)3
Avg Revenue beat(4)2.93%
Min Revenue beat(4)-1.12%
Max Revenue beat(4)6.26%
Revenue beat(8)7
Avg Revenue beat(8)3.52%
Revenue beat(12)10
Avg Revenue beat(12)3.33%
Revenue beat(16)13
Avg Revenue beat(16)4.02%
PT rev (1m)2.05%
PT rev (3m)10.64%
EPS NQ rev (1m)-1.32%
EPS NQ rev (3m)8.25%
EPS NY rev (1m)1.41%
EPS NY rev (3m)4.52%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)6.38%
Revenue NY rev (1m)1.62%
Revenue NY rev (3m)5.48%
Valuation
Industry RankSector Rank
PE 59.36
Fwd PE 34.32
P/S 5.47
P/FCF 18.96
P/OCF 16.45
P/B 24.45
P/tB 25.72
EV/EBITDA 32.13
EPS(TTM)40.66
EY1.68%
EPS(NY)70.33
Fwd EY2.91%
FCF(TTM)127.28
FCFY5.27%
OCF(TTM)146.69
OCFY6.08%
SpS441.4
BVpS98.7
TBVpS93.83
PEG (NY)1.74
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.45%
ROE 41.19%
ROCE 29.8%
ROIC 21.15%
ROICexc 130.55%
ROICexgc 155.15%
OM 12.81%
PM (TTM) 9.21%
GM 46.13%
FCFM 28.84%
ROA(3y)5.57%
ROA(5y)3.5%
ROE(3y)34.15%
ROE(5y)21.57%
ROIC(3y)18.86%
ROIC(5y)13.44%
ROICexc(3y)207.02%
ROICexc(5y)N/A
ROICexgc(3y)457.7%
ROICexgc(5y)N/A
ROCE(3y)26.57%
ROCE(5y)18.94%
ROICexcg growth 3Y46.42%
ROICexcg growth 5YN/A
ROICexc growth 3Y51.24%
ROICexc growth 5YN/A
OM growth 3Y25.83%
OM growth 5YN/A
PM growth 3Y98.37%
PM growth 5YN/A
GM growth 3Y2.74%
GM growth 5Y-0.81%
F-Score5
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 1
Debt/EBITDA 0.82
Cap/Depr 154.96%
Cap/Sales 4.4%
Interest Coverage 250
Cash Conversion 212.43%
Profit Quality 313.1%
Current Ratio 1.2
Quick Ratio 1.18
Altman-Z 4.68
F-Score5
WACC9.2%
ROIC/WACC2.3
Cap/Depr(3y)116.48%
Cap/Depr(5y)176.74%
Cap/Sales(3y)3.99%
Cap/Sales(5y)5.36%
Profit Quality(3y)451.37%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.92%
EPS 3Y172.65%
EPS 5YN/A
EPS Q2Q%43.66%
EPS Next Y34.07%
EPS Next 2Y36.58%
EPS Next 3Y36.18%
EPS Next 5Y31.77%
Revenue 1Y (TTM)37.68%
Revenue growth 3Y43.24%
Revenue growth 5Y55.35%
Sales Q2Q%36.97%
Revenue Next Year32.66%
Revenue Next 2Y28.71%
Revenue Next 3Y26.29%
Revenue Next 5Y20.91%
EBIT growth 1Y23.69%
EBIT growth 3Y80.24%
EBIT growth 5YN/A
EBIT Next Year76.57%
EBIT Next 3Y44.13%
EBIT Next 5Y34.95%
FCF growth 1Y78.01%
FCF growth 3Y170.77%
FCF growth 5Y86.33%
OCF growth 1Y84.45%
OCF growth 3Y101.69%
OCF growth 5Y77.37%